HBV mutation literature information.


  [Risk factors analysis and a new risk scoring system predicting hepatocarcinogenesis for chronic genotype C HBV infected patients].
 PMID: 30462954       2018       Zhonghua liu xing bing xue za zhi
Abstract: In genotype C HBV infected patients, male gender, aged 40 years and over, and four DNA mutations (T1674CG, A1762T/G1764A, A3120T, and A2962G) can increase the risk of HCC (P<0.05); interferon therapy can reduce the risk of HCC (P<0.05).


  Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk.
 PMID: 23516510       2013       PloS one
Abstract: In multivariate regression analyses, rs4938723 in dominant model increased HCC risk (AOR = 1.62, 95% CI = 1.05-2.49), whereas its multiplicative interaction with C1730G, a HBV mutation inversely associated with HCC risk, reduced HCC risk (AOR = 0.34, 95% CI = 0.15-0.81); rs11614913 strengthened the G1896A effect but attenuated the A3120G/T effect on HCC risk.
Result: In those with the data of HBV mutations in the preS region, pri-miR-34b/c rs4938723 in dominant genetic model was significantly associated with an increased risk of HCC whereas its int


  Association of novel mutations and haplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma.
 PMID: 21104161       2010       Frontiers of medicine in China
Abstract: C2875A, G2950A, G2951A, A3054T, C3060T, T3066A, T3069G, A3120T, and G3191C were significantly associated with increased risks of HCC in genotype C, whereas these mutations were inversely associated with HCC in genotype B.



Browser Board

 Co-occurred Entities




   Filtrator